A cute kidney injury (AKI) affects 5% to 7% of all hospitalized patients (1) with a much higher incidence in the critically ill. Although AKI carries considerable morbidity and mortality (1, 2) Ͼ35 definitions of AKI have been used in the literature. This results in confusion as well as an ill-defined association between acute renal dysfunction and morbidity and mortality (2, 3) . Hence, in 2002, the Acute Dialysis Quality Initiative defined universal AKI criteria for the first time (4) . This definition was the first consensus classification to integrate both urine output and creatinine measurements. The Acute Dialysis Quality Initiative definition resulted in extensive debate about its prediction of outcomes (5) (6) (7) (8) and did not include a complete definition for renal replacement therapy (RRT). Therefore, in 2005, it was revised by the Acute Kidney Injury Network (AKIN) using more updated serum creatinine and urine output criteria and including information regarding RRT. Furthermore, the definition of time to occurrence of kidney injury was narrowed from 7 days to 48 hrs, emphasizing the acute nature of this disorder (9) .
In recent years, two large multicenter studies have been performed to validate this relatively new classification: The Simplified Acute Physiology Score 3 Hospital Outcome Cohort having data from 303 intensive care units (10) and the Riyadh Intensive Care Program database with data from 22 intensive care units (11) . Both of these studies demonstrated an increased morbidity and mortality associated with the development of AKI. However, both used modified AKIN criteria and neither used accurate urine output measurement for the detection of AKI.
Recently an American Thoracic Society statement aimed to prevent the development of AKI (12) by emphasizing the Objective: Acute kidney injury affects 5% to 7% of all hospitalized patients with a much higher incidence in the critically ill. The Acute Kidney Injury Network proposed a definition in which serum creatinine rises (>0.3 mg/dL) and/or oliguria (<0.5 mL/kg/hr) for a period of 6 hrs are used to detect acute kidney injury. Accurate urine output measurements as well as serum creatinine values from our database were used to detect patients with acute kidney injury and calculate their corresponding mortality risk and length of stay.
Design: Retrospective cohort study. Setting: Seven intensive care units at a large, academic, tertiary medical center.
Patients: Adult patients without evidence of end-stage renal disease with more than two creatinine measurements and at least a 6-hr urine output recording who were admitted to the intensive care unit between 2001 and 2007.
Interventions: Medical records of all the patients were reviewed. Demographic information, laboratory results, charted data, discharge diagnoses, physiological data, and patient outcomes were extracted from the Multiparameter Intelligent Monitoring in Intensive Care II database using a SQL query.
Measurements and Main
Results: From 19,677 adult patient records, 14,524 patients met the inclusion criteria. Fifty-seven percent developed acute kidney injury during their intensive care unit stay. Inhospital mortality rates were: 13.9%, 16.4%, 33.8% for acute kidney injury 1, 2, and 3, respectively, compared with only 6.2% in patients without acute kidney injury (p < .0001). After adjusting for multiple covariates, acute kidney injury was associated with increased hospital mortality (odds ratio 1.4 and 1.3 for acute kidney injury 1 and acute kidney injury 2 and 2.5 for acute kidney injury 3; p < .0001). Using multivariate logistic regression, we found that in patients who developed acute kidney injury, urine output alone was a better mortality predictor than creatinine alone or the combination of both.
Conclusions: More than 50% of our critically ill patients developed some stage of acute kidney injury resulting in a stagewise increased mortality risk. However, the mortality risk associated with acute kidney injury stages 1 and 2 does not differ significantly. In light of these findings, re-evaluation of the Acute Kidney Injury Network staging criteria should be considered. (Crit Care Med 2011; 39:2659 -2664) KEY WORDS: acute kidney injury; epidemiology; incidence; outcome; urinary output; creatinine; critical care significance of urine output measurement in the continuous evaluation of critically ill patients to facilitate early detection of AKI. The Multiparameter Intelligent Monitoring in Intensive Care II (MIMIC-II) database (13) , unlike the two databases used in the previously mentioned studies, has high-resolution urine measurements and can therefore more accurately detect the development of the various stages of AKI.
We designed a study aimed to estimate the risk for morbidity and mortality of patients who developed AKI solely using the large cohort of critically ill patients from the MIMIC-II database. Our study was designed to test the hypothesis that occurrence of AKI would predict mortality in critically ill patients and that varying stages of AKI (detected by applying the AKIN criteria) would yield different levels of attributable mortality. Such data are critical to the validation of the AKI definition criteria; for example, if the inclusion of oliguria did not improve predictive value beyond creatinine rise, then one might argue to refine the definition based on creatinine alone.
METHODS
The MIMIC-II Database. The MIMIC-II project was approved by the Institutional Review Boards of the Massachusetts Institute of Technology and Beth Israel Deaconess Medical Center and granted a waiver of informed consent. The MIMIC-II database includes physiological information from bedside monitors in seven adult intensive care units (ICUs) of Beth Israel Deaconess Medical Center, a large, academic, tertiary medical center in Boston, MA. These data (heart rate, blood pressure, etc.) were validated by ICU nurses on an hourly basis. The database also contains records of all laboratory values, nursing progress notes, intravenous medications, fluid intake/output, and other clinical variables. Other clinical data were added to the database including pharmacy provider order entry records, admission and death records, discharge summaries, International Classification of Diseases, 9th Revision (ICD-9) codes, and imaging and electrocardiographic reports. The database also contains bedside monitor waveforms and their associated derived parameters, which were not investigated in this research. The database includes patients admitted between 2001 and 2007 and is maintained by researchers at the Harvard-Massachusetts Institute of Technology Division of Health Sciences and Technology (details at http://physionet.org/mimic2).
Inclusion and Exclusion Criteria. We included all adult patients with ICU length of stay of Ͼ24 hrs who had at least two serum creatinine measurements and at least one 6-hr urine output observation period (see "Definition of AKI").
Patients who underwent RRT on the day of or before their hospital admission or who had a first serum creatinine level of Ͼ4 mg/dL were categorized as having end-stage renal disease (ESRD) and therefore were excluded. Patients were also excluded if they had an ICD-9 code for ESRD. Because the MIMIC-II database did not have a specific coding system for RRT, patients were considered to have undergone RRT if they had the words "end-stage renal disease" or "dialysis" (or equivalent, i.e., continuous venovenous hemofiltration, continuous venovenous hemodialysis, RRT, etc.) in text notes on the day of admission. To validate this text search, sampling of 100 patients was performed. In 98% (95% confidence interval [CI] 95.3-100) of the sampled cases, the patients indeed underwent RRT on the day of admission.
Definition of AKI. We classified our patients into three classes according to AKIN criteria (9) ( Table 1 ). The AKIN class was determined by using serum creatinine measurements from laboratory reports and urine output (UO) measurements that were recorded as part of the nursing flow sheet. In general, UO measurements are entered hourly and the AKI criteria require UO over a 6-hr window. To account for absences from the ICU and misentered information, the total UO over the window was determined in two steps. First, take a 6-hr period after each UO measurement having at least three additional measurements. Second, calculate the weight-normalized total UO during this 6-hr period.
Because our database did not include the preadmission serum creatinine level of the patients, we considered the lowest serum creatinine level of a patient to be equivalent to the patient's prehospital baseline serum creatinine level. The worst serum creatinine increase or UOs were examined in 48-hr periods. The most severe AKI stage (from UOs or creatinine measurements, whichever was more severe) was recorded for every patient. Patients who received some kind of RRT were classified as AKI 3 (AKIN criteria).
Data Collection. All data were extracted from the MIMIC-II database (v2.5). The extracted data included demographic information (e.g., age, sex) as well as clinical information from laboratory results (e.g., serum creatinine and arterial blood gases), nursingcharted data (e.g., UO), and discharge diagnoses ICD-9 codes). Physiological data were collected only during the ICU stay, unlike laboratory results, which were available throughout the whole hospitalization.
Physiological data including heart rate, blood pressure, respiratory rate, length of mechanical ventilation, neurologic status (Glasgow Coma Score) as well as nonrenal Sequential Organ Failure Assessment (SOFA) scores (14) (calculated SOFA score excluding the renal component) were computed and reported.
Recorded outcomes such as mortality and length of stay were also extracted from the same database.
Statistical Analysis. STATA 11.1 (Stata-Corp, Collage Station, TX) was used for all statistical analysis. All continuous variables were expressed either as mean Ϯ SE and 95% CI or as median and interquartile (Q1-Q3).
For the univariate analysis, we used the chi-square tests, t tests, Kruskal-Wallis oneway analysis of variance and Mann-Whitney U test to evaluate statistical significance. All tests were two-sided, and a p value of Ͻ.05 was considered significant.
For the multivariate analysis, we performed a logistic regression analysis with a dependent variable of inhospital mortality and ICU mortality. The following covariates included in the models were considered to be related to mortality and morbidity in critically ill patients: age, gender, SOFA scores, AKI stage, and comorbidity groups taken from ICD-9 -Clinical Modification codes using the Elixhauser's comorbidity index (15) (groups were: disease of the respiratory, gastrointestinal, and circulatory systems as well as infectious diseases, malignancy, diabetes mellitus, gastrointestinal bleeding, coronary artery disease, congestive heart failure, peripheral vas- 1 Serum creatinine 200% to 300% (more than two-to threefold) from baseline Ͻ0.5 mL/kg/hr for Ͼ12 hrs 3
1 Serum creatinine Ͼ300% (more than threefold) from baseline or serum creatinine Ն4 mg/mL (Ն354 mol/L) with an acute increase of at least 0.5 mg/ mL (44 mol/L) or need for renal replacement therapy Ͻ0.3 mL/kg/hr for Ͼ24 hrs or anuria for 12 hrs a The patient's acute kidney injury stage depends on the worst stage definition from the urine output criteria or serum creatinine criteria (e.g., an anuric patient ͓urine criteria stage 3͔ with an increase of 1.5 in creatinine ͓serum creatinine criteria stage 1͔ will have an overall acute kidney injury stage 3). cular disease, cirrhosis, and gastrointestinal bleeding). After controlling for colinearity, we applied a stepwise (forward and backward) selection of the covariates; the covariates that were used in our logistic regression analysis were: age, SOFA score on admission, diseases of the respiratory and gastrointestinal systems, sepsis, cirrhosis, gastrointestinal bleeding, malignancy, congestive heart failure, diabetes mellitus, coronary artery disease, and peripheral vascular disease.
We analyzed hospital survival across groups using the Kaplan-Meier methods, and we tested differences between groups using the log-rank test.
RESULTS
The MIMIC-II database contains the records of 26,510 patients of whom 19,677 were adults aged Ն15 yrs at the time of admission. Six hundred thirty patients were excluded because they were considered to have had ESRD before their ICU admission; of these patients, 327 were excluded by the text search of the medical notes and 303 as a result of the presence of an ICD-9 code for ESRD. A total of 1,755 patients were excluded because they did not have sufficient creatinine measurements or their length of stay was Յ1 day and 2,768 because they did not have sufficient UO recordings (Fig. 1) .
The final analytic cohort, therefore, contained 14,524 patients, of which 6,161 were females (42%). The median age on admission was 65.8 yrs (Q1-Q3, 55.2-77.8). The median SOFA score (nonrenal) on admission was 5 (Q1-Q3, 2-8) ( Table  2) . Fifty-seven percent of the patients developed AKI during their ICU stay. AKI 1 was the most frequent (38.5%) followed by AKI 2 (14.1%) and AKI 3 (4.3%). The overall inhospital and ICU mortality rates were 11.8% and 9%, respectively. Hospital mortality rates were higher in patients with AKI (16% vs. 6.7%; p Ͻ .0001) than in patients with no AKI. The same was found for ICU mortality rates (12.4% vs. 4.8%; p Ͻ .0001). The univariate inhospital mortality odds ratios (ORs) were 2.41, 2.95, and 7.64 for patients with AKI 1, AKI 2, and AKI 3, respectively, compared with patients with no AKI (p Ͻ .0001 for all). The multivariate logistic regression model included age, admission SOFA score (without renal component), diseases of the respiratory and gastrointestinal systems, sepsis, cirrhosis, gastrointestinal bleeding, malignancy, congestive heart failure, diabetes mellitus, coronary artery disease, and peripheral vascular disease (Table 3) . Patients with AKI 1 and AKI 2, compared with patients without AKI, had a 30% increase in the odds of death (AKI 1: OR 1.38; 95% CI 1.2-1.59, p Ͻ .0001; AKI 2: OR 1.26; 95% CI 1.06 -1.5, p ϭ .01); patients with AKI 3 were 2.5 times more likely to die (95% CI 1.98 -3.12, p Ͻ .0001) ( Table 3 ). The 28-day Kaplan-Meier survival plot (Fig. 2) clearly shows a diversion of the survival rates among the three different AKI stages (log-rank [Mantel-Cox] test p Ͻ .0001); because the survival probability of AKI 1 patients is again similar to that of patients with AKI 2, one could question the existence of two separate groups.
Analysis of ICU mortality rates was similar to inhospital mortality rates. In univariate analysis, the ORs for ICU mortality were 2.35, 3.2, and 9.2 for AKI 1, 2, and 3, respectively, compared with patients with no AKI (p Ͻ .0001). When we applied the same multivariate logistic regression model as for the inhospital mortality, the ORs for ICU mortality were increased to 1.27 for AKI 1 and AKI 2 and 3.7 for AKI 3 compared with patients with no AKI (p Ͻ .0001) ( Table 4 ).
Patients with AKI had a significant decrease in median 28 ICU-free days (16) , from 26 (23.1-26.9) for patients without AKI to 22 (0 -25.7), 17 (0 -24.8), and 0 (0 -19.8) days for patients with AKI 1, 2, and 3, respectively (p Ͻ .0001) ( Table 5 ). The length of ICU stay for patients who developed AKI was longer than for those who did not develop AKI and increased gradually with the severity of AKI from a mean ICU stay of 2.3 days for patients without AKI to 5.6, 8.2, and 12.6 days for AKI 1, 2, and 3, respectively (p Ͻ .0001) ( Table 5 ).
The classification of AKIN for the development of AKI is based on the combination of two components: UO measurements and serum creatinine (CR) increases in a 48-hr window. We examined the ability of each component of the AKIN criteria (UO or CR) to predict mortality independently. First, we computed area under the curve (AUC) for AKI categorized by UO from ten-fold cross-validation using a logistic regression analysis (the same covariates were included as previously mentioned). We then computed the AUC for AKI using CR. We then compared areas under the receiver operating characteristic curve corresponding to UO and CR.
Regarding the subset of patients without AKI, we found that the mortality predictive ability of CR was superior to that of UO (AUC [CR] ϭ 0.780 vs. AUC [UO] ϭ 0.764; p Ͻ .0001). However, for the subset of patients who developed AKI, divided according to severity stages, we found that the mortality predictive ability of UO was always superior to that of CR: AKI 1Ϫ AUC (UO) ϭ 0.741 vs. AUC (CR) ϭ 0.714; p ϭ .005; AKI 2Ϫ AUC (UO) ϭ 0.722 vs. AUC (CR) ϭ 0.655; p ϭ .001; AKI 3Ϫ AUC (UO) ϭ 0.763 vs. AUC (CR) ϭ 0.660; p ϭ .001 (Table 6 ).
DISCUSSION
Our analysis of a cohort of Ͼ14,000 patients, from a single, large, academic center, using the AKIN proposed acute kidney classification on data from the MIMIC-II database, showed a clear and significant increase in the risk for mortality in patients who developed AKI compared with patients who did not. The increased risk was found to be proportional to the stage of AKI, although there is no clear risk difference between the patients with AKI 1 and AKI 2 compared with a large increase in mortality risk in patients with AKI 3. These results are consistent with previous studies, in which the authors hypothesized that an inaccurate use of the criteria, specifically data regarding UO, which, by their nature, can be inaccurately collected, were the cause for this phenomenon (11) . In contrast with the aforementioned studies, the MIMIC-II database allowed us to follow UO measurements in a higher resolution (6-hr windows) and therefore fully meet UO criteria as designed in the AKIN classification. Nevertheless, we still did not see a significant difference between AKI 1 and 2 regarding the risk of mortality. This finding suggests that although these patients are classified as two different groups according to the AKIN classification, this division should be reconsidered.
The increased mortality rate, especially in the less severe AKI groups (1 and 2), may be explained by an indirect rather than a direct mechanism. In the past, there have been studies that demonstrated that kidney injury can influence morbidity and mortality directly by causing water and salt retention leading to hyperkalemia, acidosis (17, 18) , and fluid overload. However, AKI has been associated with increased insulin resistance and protein breakdown that can lead to immune system dysfunction. This can create an indirect influence on morbidity and mortality, particularly given that sepsis is the most common mechanism of death in AKI (16) . Kidney injury can also cause activation of the immune system that promotes the secretion of proinflammatory cytokines that can lead to an increased activity of pulmonary macrophages; this could result in increased pulmonary capillary permeability and cause respiratory compromise (19) . Accumulating data, including our results, show that although kidney injury is not always directly related to the cause of death, it is clearly a marker of worsening patient status and may be a useful clinical marker of deterioration. We therefore suggest that it might be used as a risk assessment tool for clinicians.
In view of this, it would seem logical to assume that tackling AKI would create a beneficial effect for these patients. However, this approach, although useful to prognosticate, remains unproven when used to direct therapy (20 -26) . We be-lieve the reason to be the multifactorial nature of AKI and the fact that it might be only a part of a systemic process rather than its cause.
There are a number of limitations to our study. First, our database did not have a specific and accurate coding system for RRT. To exclude patients who had ESRD, we had to use a text search. We have tried to overcome this limitation by refining the search and by sampling of 100 patients (of 630 excluded patients) to ensure that patients who were excluded indeed had ESRD. The results were that in 98% of these sampled cases, patients have had RRT on the day of admission and were appropriately excluded. Because the misclassification rate in the manual review was 2% (95% CI, 0% to 4.7%), a simulated 5% misclassification rate among patients coded as having ESRD resulted in the movement of only 32 pa-tients from ESRD to the cohort. The mortality rate and calculated OR for various AKI stages did not differ from the original cohort. Second, the database contains data from a period of 7 yrs (2001) (2002) (2003) (2004) (2005) (2006) (2007) , during which there were changes in management of the critically ill and therefore possibly in patient outcome. Because the MIMIC-II database is completely deidentified, we were unable to divide the patients into groups that correspond to their different treatment periods. Finally, although our study included the data of Ͼ14,000 patients and had strong statistical power, it was still a retrospective analysis with its characteristic limitations.
The use of lowest creatinine during hospital stay at baseline creatinine level can be also considered a limitation. However, a number of studies have demonstrated the inaccuracy of other commonly used methods for the calculation of baseline serum creatinine level (i.e., Modification of Diet in Renal Disease formula), especially in patients with pre-AKI reduced glomerular filtration rate (27, 28) . Therefore, we decided to use the lowest serum creatinine level of a patient during his or her hospital stay as baseline CR level.
CONCLUSION
In view of AKI's tremendous effect on prognosis, we propose using the AKI classification as a risk assessment tool for clinicians. Larger prospective randomized controlled trials are needed to examine whether the application of treatment measurements targeting the AKI will improve patient prognosis. OR, odds ratio; AKI, acute kidney injury. a Area under the receiver operating characteristic curve for inhospital mortality prediction based on the logistic regression models ϭ 0.799. 
